Literature DB >> 6356462

Ticlopidine hydrochloride: relationship between dose, kinetics, plasma concentration and effect on platelet function.

C Picard-Fraire.   

Abstract

This is a review of the available data about the pharmacodynamic profile of ticlopidine in man in relation to its pharmacokinetic and metabolic characteristics. There is a rapid dose-dependent onset of effect on platelet function and a time-dependent effect on bleeding. The ticlopidine effect appears to be due to the direct action on circulating platelets. The contributions of a metabolite, a 2-keto derivative, is also discussed.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6356462     DOI: 10.1016/0049-3848(83)90367-5

Source DB:  PubMed          Journal:  Thromb Res Suppl        ISSN: 0896-0569


  9 in total

1.  Pharmacodynamics of ticlopidine in man in relation to plasma and blood cell concentration.

Authors:  T DiPerri; F L Pasini; C Frigerio; P Blardi; F Centini; G L Messa; A Ghezzi; L Volpi
Journal:  Eur J Clin Pharmacol       Date:  1991       Impact factor: 2.953

2.  The P2Y(12) receptor as a target of antithrombotic drugs.

Authors:  Stephen O'Connor; Gilles Montalescot; Jean-Philippe Collet
Journal:  Purinergic Signal       Date:  2011-06-28       Impact factor: 3.765

Review 3.  Ticlopidine. A review of its pharmacology, clinical efficacy and tolerability in the prevention of cerebral ischaemia and stroke.

Authors:  S Noble; K L Goa
Journal:  Drugs Aging       Date:  1996-03       Impact factor: 3.923

4.  Analysis of antiplatelet effect of ticlopidine in humans: modeling based on irreversible inhibition of platelet precursors in bone marrow.

Authors:  M Katashima; Y Yamada; K Yamamoto; H Kotaki; H Sato; Y Sawada; T Iga
Journal:  J Pharmacokinet Biopharm       Date:  1999-06

5.  Identification of the active metabolite of ticlopidine from rat in vitro metabolites.

Authors:  Kenji Yoneda; Ryou Iwamura; Hiroko Kishi; Yoichi Mizukami; Kimiko Mogami; Sei Kobayashi
Journal:  Br J Pharmacol       Date:  2004-05-17       Impact factor: 8.739

Review 6.  Pharmacokinetic optimisation of the treatment of embolic disorders.

Authors:  D M Lutomski; M Bottorff; K Sangha
Journal:  Clin Pharmacokinet       Date:  1995-01       Impact factor: 6.447

Review 7.  Clinical pharmacokinetics of ticlopidine.

Authors:  J P Desager
Journal:  Clin Pharmacokinet       Date:  1994-05       Impact factor: 6.447

8.  Pharmacokinetics and pharmacodynamics of L-703,014, a potent fibrinogen receptor antagonist, after intravenous and oral administration in the dog.

Authors:  J S Barrett; R J Gould; J D Ellis; M M Holahan; M T Stranieri; J J Lynch; G D Hartman; N Ihle; M Duggan; O A Moreno
Journal:  Pharm Res       Date:  1994-03       Impact factor: 4.200

Review 9.  Evolving role of platelet function testing in coronary artery interventions.

Authors:  Rakesh K Sharma; Donald J Voelker; Rohit Sharma; Hanumanth K Reddy; Harvinder Dod; James D Marsh
Journal:  Vasc Health Risk Manag       Date:  2012-02-08
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.